Ranked in 1 Practice Areas
2

Band 2

ERISA Litigation: Mainly Plaintiffs

USA - Nationwide

1 Years Ranked

About

Provided by Lynn Lincoln Sarko

USA

Practice Areas

Appeals

Class Action & Consumer Litigation

Drug Pricing Resource Center

ERISA & Employee Benefits

Environmental Litigation

Institutional Investors

International Law

Career

Managing Partner Lynn Sarko uses thoughtful innovation to solve complex issues.

Having led Keller Rohrback L.L.P.’s Complex Litigation Group since its inception over 30 years ago, Lynn’s work has led to new developments in case law and significant, impactful settlements for his clients.

A dynamic leader with a tenacious dedication to justice, Lynn has been selected by courts across the nation to serve in key leadership roles in a wide variety of cutting-edge cases. Namely, he was appointed Co-Lead counsel for In re EpiPen (Epinephrine Injection, USP) Mktg., Sales Practices & Antitrust Litigation, MDL No. 2785 (D. Kan.), the nationwide class action against pharmaceutical company Mylan and others for anticompetitive and unfair business practices in its sale and marketing of the EpiPen Auto-Injector device. He was also selected to serve in a leadership position on behalf of governmental entities and other plaintiffs in the vast litigation regarding the nationwide prescription opioid epidemic, In re National Prescription Opiate Litigation, MDL No. 2804 (N.D. Ohio). The National Law Journal referred to this leadership team as a “‘Who’s Who’ in mass torts.”

Chambers Review

Provided by Chambers

USA

ERISA Litigation: Mainly Plaintiffs - USA - Nationwide
2
Band 2

Lynn Lincoln Sarko is a noted litigator proficient handling ERISA matters on behalf of plaintiffs.

Strengths

Provided by Chambers

Discover other Lawyers at
Keller Rohrback LLP

Provided by Chambers
Filter by
Band

Oregon

Litigation: General Commercial

3
Jen Wagner
3
Band 3

USA - Nationwide

ERISA Litigation: Mainly Plaintiffs

Jeffrey Lewis
2
Jeffrey Lewis
2
Band 2
Lynn Lincoln Sarko
2
Lynn Lincoln Sarko
2
Band 2